Titelia

Holdings of DAFNA Capital Management LLC

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
69 in 5 countries
Top ten
57.6 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Revolution Medicines Inc 580,67856.5M $
2SPDR Series Trust 318,50540.7M $
3Stereotaxis Inc 13,680,55425.2M $
4Day One Biopharmaceuticals Inc 978,46321M $
5AtriCure Inc 597,43117M $
6Ideaya Biosciences Inc 476,74015.9M $
7Cytokinetics Inc 217,49714.3M $
8Compass Pathways plc 2,418,88213.4M $
9Nektar Therapeutics 165,17811.9M $
10iShares Biotechnology ETF 62,09510.5M $
11Arcus Biosciences Inc 443,8299.6M $
12Neurocrine Biosciences Inc 70,6159.3M $
13Larimar Therapeutics Inc 2,029,1649.1M $
14Bicara Therapeutics Inc 421,7338.4M $
15Axogen Inc 249,9608.3M $
16Tandem Diabetes Care Inc 355,2086.8M $
17Denali Therapeutics Inc 318,5006.1M $
18Century Therapeutics Inc 2,434,3535.5M $
19Dexcom Inc 86,2795.4M $
20KalVista Pharmaceuticals Inc 267,4025.4M $
21Ascendis Pharma A/S 23,1775.3M $
22MBX Biosciences Inc 175,4655.2M $
23Inogen Inc 845,1795.2M $
24Syndax Pharmaceuticals Inc 217,3555.1M $
25Stoke Therapeutics Inc 130,8754.3M $
26BioCryst Pharmaceuticals Inc 430,2484.1M $
27Galapagos NV 130,1753.9M $
28Immunovant Inc 150,5243.7M $
29Edgewise Therapeutics Inc 112,2363.5M $
30MapLight Therapeutics Inc 171,0063.5M $
31Allogene Therapeutics Inc 1,370,1183.3M $
32PROCEPT BIOROBOTICS CORP 120,0003M $
33Align Technology Inc 15,0002.6M $
34Rapport Therapeutics Inc 75,0002.3M $
35Insulet Corp 10,8702.3M $
36Structure Therapeutics Inc 46,5002.2M $
37Celldex Therapeutics Inc 68,5182.2M $
38Lexeo Therapeutics Inc 377,0592.2M $
39Alector Inc 908,3512M $
40Viking Therapeutics Inc 59,5161.9M $
41Kura Oncology Inc 235,8681.9M $
42Fulcrum Therapeutics Inc 205,0001.6M $
43Aquestive Therapeutics Inc 368,4151.5M $
44OrthoPediatrics Corp 95,6591.5M $
45Ultragenyx Pharmaceutical Inc 61,1001.3M $
46Neurogene Inc 56,6351.1M $
47ARS Pharmaceuticals Inc 139,2851.1M $
48CytomX Therapeutics Inc 230,0001.1M $
49Maze Therapeutics Inc 35,0001M $
50Mineralys Therapeutics Inc 38,4901M $
51SCYNEXIS INC 1,086,956996.6K $
52ORIC Pharmaceuticals Inc 98,724945.5K $
53Inspire Medical Systems Inc 18,200938.8K $
54TELA BIO INC 1,441,029893.4K $
55ZENAS BIOPHARMA INC 42,500830.9K $
56Verrica Pharmaceuticals Inc 153,712813.1K $
57Fate Therapeutics Inc 550,000660K $
58Annexon Inc 117,812652.7K $
59Accuray Inc 1,680,508652.2K $
60Adicet Bio Inc 93,812638.9K $
61BioNTech SE 7,000622.2K $
62Pliant Therapeutics Inc 487,000613.6K $
63Orchestra BioMed Holdings Inc 126,841539.1K $
64Foghorn Therapeutics Inc 111,859534.7K $
65IBIO INC 193,638367.9K $
66Bicycle Therapeutics PLC 64,492299.2K $
67Karyopharm Therapeutics Inc 45,800255.1K $
68Autolus Therapeutics PLC 179,316247.5K $
69Neumora Therapeutics Inc 70,000136.5K $

Download this table: CSV, JSON

Sector breakdown

  • Health care 1.4 %
  • Unattributed 98.6 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • United States 94.0 %
  • United Kingdom 3.5 %
  • Denmark 1.3 %
  • Belgium 1.0 %
  • Germany 0.2 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1United States63369.2M $93.96 %
2United Kingdom313.9M $3.54 %
3Denmark15.3M $1.35 %
4Belgium13.9M $0.99 %
5Germany1622.2K $0.16 %
Cite this page

Titelia. "Holdings of DAFNA Capital Management LLC". https://titelia.com/en/funds/US13F1389933